Inhibition of bcl-2 as cancer therapy.
Ciardiello
F
F
Tortora
G
G
D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000235:genetics; D002986:Clinical Trials as Topic; D018450:Disease Progression; D019254:Genes, bcl-2; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000494:pharmacology; D013873:Thionucleotides / Q000494:pharmacology*; D016896:Treatment Outcome
D016376:Oligonucleotides, Antisense; D019253:Proto-Oncogene Proteins c-bcl-2; D013873:Thionucleotides; C408162:oblimersen